Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Neuraxis, Inc. (NRXS) vs PMV Pharmaceuticals, Inc. (PMVP)

Neuraxis, Inc. and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Neuraxis, Inc. and PMV Pharmaceuticals, Inc. are of similar size ($100.8M and $97.3M). PMV Pharmaceuticals, Inc. has the higher net margin (0.00% vs −159.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PMV Pharmaceuticals, Inc. leads on 7 and Neuraxis, Inc. on 5.

Valuation

Metric NRXS PMVP Biotechnology median
P/E n/m n/m 7.88
P/S 17.24 n/m 11.47
P/B 13.61 0.99 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.10 0.74
EV/Sales 15.68 n/m 10.73
Earnings yield (10.32%) (106.77%) (28.84%)
Free cash flow yield (6.31%) (100.36%) (23.03%)

Profitability

Metric NRXS PMVP Biotechnology median
Gross margin 85.56% 0.00% 65.16%
Operating margin (144.51%) 0.00% 0.00%
Net margin (159.01%) 0.00% 0.00%
Free cash flow margin (106.10%) 0.00% 0.00%
Return on equity (153.96%) (70.93%) (57.72%)
Return on assets (98.96%) (64.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXS PMVP Biotechnology median
Revenue growth (TTM) 65.22% — 5.64%
EPS growth (last fiscal year) 22.13% (29.82%) —
Revenue growth, 5-year CAGR 13.08% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXS PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.04 7.70 4.73
Net debt to EBITDA 0.64 1.27 0.96

Dividend

Metric NRXS PMVP Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric NRXS PMVP Biotechnology median
Market cap 97.32m 100.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack